The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency

Stem Cell Research and Therapy

Volumn 6, Issue 1, 2015, Pages

  Zekri, Abdel Rahman N ^a   Salama, Hosny ^b   Medhat, Eman ^b   Musa, Sherief ^b   Abdel Haleem, Hanan ^b   Ahmed, Ola S ^a   Khedr, Hanan Abdel Hafez ^b   Lotfy, Mai M ^a   Zachariah, Khaled S ^b   Bahnassy, Abeer A ^c  

^a CAIRO UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

^c NATIONAL CANCER INSTITUTE   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; FILGRASTIM; SERUM ALBUMIN; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; ASCITES; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHILD PUGH SCORE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INTERNATIONAL NORMALIZED RATIO; LIVER CIRRHOSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPEAT PROCEDURE; SAFETY; TREATMENT OUTCOME; TREATMENT RESPONSE; AUTOTRANSPLANTATION; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CLINICAL TRIAL; COMPLICATION; CYTOLOGY; DIAGNOSTIC IMAGING; ECHOGRAPHY; FOLLOW UP; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS C; LIVER; LIVER FUNCTION TEST; METABOLISM; MIDDLE AGED; MORTALITY; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

ADULT; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; FOLLOW-UP STUDIES; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HEPATITIS C; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; ULTRASONOGRAPHY;

EID: 84933533553     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/s13287-015-0106-1     Document Type: Article

References (34)

1. Sakaida I. Autologous bone marrow cell infusion therapy for liver cirrhosis. J Gastroenterol Hepatol. 2008;23:1349-53.
2. Weissman I. Stem cells: units of development, units of regeneration and units in evolution. Cell. 2000;105:829-41.
3. Pauwelyn K, Verfaillie C. Transplantation of undifferentiated, bone marrow-derived stem cells. Curr Top Dev Biol. 2006;74:201-51.
4. Alison M, Poulsom R, Jeffery R, et al. Hepatocytes from non-hepatic adult stem cells. Nature. 2000;406:257.
5. Theise N, Nimmakayalu M, Gardner R, et al. Liver from bone marrow in humans. Hepatology. 2000;32:11-6.
6. Terai S, Ishikawa T, Omori K, et al. Improved liver function in liver cirrhosis patients after autologous bone marrow cell infusion therapy. Stem Cells. 2006;24:2292-8.
7. Jang Y, Collector M, Baylin S, et al. Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol. 2004;6:532-9.
8. Vassilopoulos G, Wang P, Russell D. Transplanted bone marrow regenerates liver by cell fusion. Nature. 2003;422:901-4.
9. 4-induced liver fibrosis in mice. Hepatology. 2004;40:1304-11.
10. Houlihan D, Newsome P. Critical review of clinical trials of bone marrow stem cells in liver disease. Gastroenterology. 2008;135:438-50.
11. Kallis Y, Alison M, Forbes S. Bone marrow stem cells and liver disease. Gut. 2007;56:716-24.
12. Salama H, Zekri A, Bahnassy A, et al. Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease. World J Gastroenterol. 2010;16:5297-305.
13. Musa S. A comparative study between infusion of non-expanded and expanded adult haematopoietic stem cells to patients with liver insufficiency. M.Sc thesis, Cairo University, Cairo, Egypt, Tropical Medicine, Faculty of Medicine, Cairo University; 2008.
14. Levicar N, Pai M, Habib N, et al. Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver disease. Cell Prolif. 2008;41:115-25.
15. Piscaglia A, Campanale M, Gasbarrini A, et al. Stem cell-based therapies for liver diseases: state of the art and new perspectives. Stem Cells Int. 2010;259461:10.
16. Yao K, Huang R, Sun A, et al. Repeated autologous bone marrow mononuclear cell therapy in patients with large myocardial infarction. Eur J Heart Fail. 2009;11:691-8.
17. Miltenyi Biotec Company. https://www.miltenyibiotec.com/en/23-06-2015.
18. Salama H, Zekri A, Medhat E, et al. Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV positive patients with end stage liver disease. Curr Stem Cell Res Ther. 2014;5:70.
19. Friedman S, Schiano T. Cirrhosis and its sequelae. In: Cecil textbook of medicine. Saunders, imprint of elsevier, United States 22nd ed. 2004. 936-44.
20. El-Zayadi E, Badran H, Barakat E, et al. Hepatocellular carcinoma in Egypt: a single study over a decade. World J Gastroenterol. 2005;11:513-9.
21. Fink M, Berry S, Gow P, et al. Risk factors for liver transplantation waiting list mortality. J Gastroenterol Hepatol. 2007;22:119-24.
22. Runyon B. Management of adult patients with ascites due to cirrhosis: AASLD practice guidelines. Hepatology. 2004;39:841-54.
23. Sipe J, Kelley C, McNicol L. Tissue engineering and reparative medicine. Ann NY Acad Sci. 2002;961:1-9.
24. Pai M, Zacharoulis D, Milicevic M, et al. Autologous infusion of expanded mobilized adult bone marrow derived CD34+ cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol. 2008;103:1952.
25. Salama H, Zekri A, Ahmed R, et al. Assessment of health-related quality of life in patients receiving stem cell therapy for end-stage liver disease: an Egyptian study. Stem Cell Res Ther. 2012;3:1-10.
26. Salama H, Zekri A, Zern M, et al. Autologous hematopoietic stem cell transplantation in 48 patients with end-stage chronic liver diseases. Cell Transplant. 2010;19:1475-86.
27. Gordon M, Levicar N, Pai M, et al. Characterisation and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells. 2006;24:1822-30.
28. Slehria S, Rajvanshi P, Ito Y, et al. Hepatic sinusoidal vasodilators improve transplanted cell engraftment and ameliorate microcirculatory perturbations in the liver. Hepatology. 2002;35:1320-8.
29. Zhang Z, Guan L, Zhang K, et al. A combined procedure to deliver autologous mesenchymal stromal cells to patients with traumatic brain injury. Cytotherapy. 2008;10:134-9.
30. Boda Z, Razso K, Szarvas M, et al. Repeated application of autologous bone marrow derived stem cell therapy in patients with severe Buerger's disease. Stem Cell Discov. 2011;1:16-9.
31. Wang K, Chen X, Ren J. Autologous bone marrow stem cell transplantation in patients with liver failure: a meta-analytic review. Stem Cells Dev. 2015;24:147-59.
32. Pan X, Zheng L, Lai X. Bone marrow-derived mesenchymal stem cell therapy for decompensated liver cirrhosis: a meta-analysis. World J Gastroenterol. 2014;20:14051-7.
33. Khanam A, Trehanpati N, Garg V, Kumar C, Garg H, Sharma BC, et al. Altered frequencies of dendritic cells and IFN-gamma-secreting T cells with granulocyte colony-stimulating factor (G-CSF) therapy in acute-on-chronic liver failure. Liver Int. 2014;34:505-13.
34. Garg V, Garg H, Khan A, Trehanpati N, Kumar A, Sharma BC, et al. Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology. 2012;142:505-12.